AssayIndex
Reports by quarter

Reports submitted in 2025-Q1 · page 12

Anomaly rule set expanded from seven rules to eleven. Median purity for the quarter is 99.14 % area, n=664. Read the 2025-Q1 state-of-the-index report →

672 records17 pagesmedian on this page 99.19 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020771SemaglutideSGNSGN-2410-D9265Janoshik2025-Q197.835.4891.6Buyer-sourced0PASS
AX-2025-020645TirzepatideGL BiochemGLBI-2412-R8446Janoshik2025-Q198.904.85—Buyer-sourced0PASS
AX-2025-019827KPVHomopeptideHOMO-2411-P5026Janoshik2025-Q199.805.64—Buyer-sourced0PASS
AX-2025-019802L-Glutathione (reduced)HomopeptideHOMO-2501-D4371Medutest2025-Q199.849.0297.0Buyer-sourced0PASS
AX-2025-019655AfamelanotideTFCTFC-2502-Y2346PeptideMeter2025-Q198.854.85—Laboratory-retained1MARGINAL
AX-2025-019607GHRP-2TFCTFC-2411-A2083Janoshik2025-Q199.761.8990.6Laboratory-retained1MARGINAL
AX-2025-019489KPVJEEPJEEP-2410-C8600Nordanalyt2025-Q199.775.62103.4Laboratory-retained0PASS
AX-2025-018953TirzepatideASYASY-{CAT}-1244Janoshik2025-Q198.475.21100.7Buyer-sourced0PASS
AX-2025-018668TirzepatideQSCQSC-2410-R5814Kestrel2025-Q199.785.35105.3Buyer-sourced0PASS
AX-2025-018543IpamorelinQYBQYB-2408-A4637Medutest2025-Q199.935.38—Laboratory-retained0PASS
AX-2025-018514BPC-157WWBWWB-2502-F3190Janoshik2025-Q199.935.47—Buyer-sourced0PASS
AX-2025-019160LL-37SinoPepSNP-2411-X3762Medutest2025-Q199.302.73102.0Laboratory-retained1MARGINAL
AX-2025-018921CJC-1295 with DACTFSTFS-{CAT}-9795PeptideMeter2025-Q199.183.17—Buyer-sourced2MARGINAL
AX-2025-018788RetatrutideFGPFGP-2501-S8023Janoshik2025-Q198.294.10—Buyer-sourced0PASS
AX-2025-020356Enclomiphene citrateMKMMKM-2408-L3879Janoshik2025-Q198.984.27—Supplier-supplied0FAIL
AX-2025-019682DihexaTFCTFC-2409-U2263Kestrel2025-Q199.936.44—Buyer-sourced0PASS
AX-2025-019667AfamelanotideTFCTFC-2502-Y2346Janoshik2025-Q199.145.0389.4Buyer-sourced2MARGINAL
AX-2025-019147TesamorelinGSPGSP-2501-G3708PeptideMeter2025-Q198.154.0495.2Buyer-sourced0PASS
AX-2025-019063MK-677 (Ibutamoren mesylate)GSPGSP-2501-R2783Medutest2025-Q199.934.98—Supplier-supplied1FAIL
AX-2025-020511MOTS-cSSASSA-2501-M6154Nordanalyt2025-Q198.112.87—Buyer-sourced0PASS
AX-2025-019786Humanin (HNG)HomopeptideHOMO-2408-A5115Kestrel2025-Q199.585.23102.2Buyer-sourced0PASS
AX-2025-019759SemaglutideHomopeptideHOMO-2501-D4523Janoshik2025-Q199.456.02—Buyer-sourced0PASS
AX-2025-019352BPC-157HYBHYB-2502-R6185Janoshik2025-Q199.774.70101.2Buyer-sourced1FAIL
AX-2025-019176Enclomiphene citrateSinoPepSNP-2412-F3914Kestrel2025-Q199.664.7898.9Supplier-supplied2FAIL
AX-2025-019146TesamorelinGSPGSP-2501-G3708Medutest2025-Q198.284.5995.0Buyer-sourced0PASS
AX-2025-020514MOTS-cSSASSA-2501-M6154Janoshik2025-Q197.913.0195.9Buyer-sourced0FAIL
AX-2025-020254Enclomiphene citrateGGPepsGGPE-2410-S2226Medutest2025-Q198.473.35—Buyer-sourced1FAIL
AX-2025-019927TirzepatideHJHJ-2502-P6662Janoshik2025-Q199.933.00—Buyer-sourced1FAIL
AX-2025-018635TirzepatideQSCQSC-2408-T5296Janoshik2025-Q199.615.40104.8Buyer-sourced0PASS
AX-2025-018560TB-500QYBQYB-2408-A4387Janoshik2025-Q199.684.95—Buyer-sourced0PASS
AX-2025-018519SemaglutideWWBWWB-2410-J3284Janoshik2025-Q199.193.2091.4Buyer-sourced0PASS
AX-2025-020633TirzepatideGL BiochemGLBI-2412-R8446Janoshik2025-Q198.773.89—Buyer-sourced0PASS
AX-2025-020507MOTS-cSSASSA-2501-M6154Janoshik2025-Q197.872.48—Buyer-sourced0FAIL
AX-2025-020260Enclomiphene citrateGGPepsGGPE-2410-S2226Janoshik2025-Q198.273.70—Buyer-sourced0FAIL
AX-2025-020258Enclomiphene citrateGGPepsGGPE-2410-S2226Janoshik2025-Q198.443.7697.1Buyer-sourced0FAIL
AX-2025-020007RetatrutideSWBSWB-2411-R7167Nordanalyt2025-Q197.904.11—Buyer-sourced0PASS
AX-2025-019903TirzepatideHJHJ-2501-P5963Kestrel2025-Q199.392.03101.4Buyer-sourced0PASS
AX-2025-018517SemaglutideWWBWWB-2410-J3284VendorInvestigate2025-Q199.333.6998.9Buyer-sourced0PASS
AX-2025-020990CJC-1295 with DACWXTWXT-2409-Y3760Janoshik2025-Q197.515.66—Supplier-supplied1MARGINAL
AX-2025-020502SermorelinKPKP-2501-V5712Nordanalyt2025-Q198.765.55105.9Buyer-sourced1MARGINAL